| Literature DB >> 18939963 |
Fumio Matsuda1, Keiko Yonekura-Sakakibara, Rie Niida, Takashi Kuromori, Kazuo Shinozaki, Kazuki Saito.
Abstract
The MS/MS spectral tag (MS2T) library-based peak annotation procedure was developed for informative non-targeted metabolic profiling analysis using LC-MS. An MS2T library of Arabidopsis metabolites was created from a set of MS/MS spectra acquired using the automatic data acquisition function of the mass spectrometer. By using this library, we obtained structural information for the detected peaks in the metabolic profile data without performing additional MS/MS analysis; this was achieved by searching for the corresponding MS2T accession in the library. In the case of metabolic profile data for Arabidopsis tissues containing more than 1000 peaks, approximately 50% of the peaks were tagged by MS2Ts, and 90 peaks were identified or tentatively annotated with metabolite information by searching the metabolite databases and manually interpreting the MS2Ts. A comparison of metabolic profiles among the Arabidopsis tissues revealed that many unknown metabolites accumulated in a tissue-specific manner, some of which were deduced to be unusual Arabidopsis metabolites based on the MS2T data. Candidate genes responsible for these biosyntheses could be predicted by projecting the results to the transcriptome data. The method was also used for metabolic phenotyping of a subset of Ds transposon-inserted lines of Arabidopsis, resulting in clarification of the functions of reported genes involved in glycosylation of flavonoids. Thus, non-targeted metabolic profiling analysis using MS2T annotation methods could prove to be useful for investigating novel functions of secondary metabolites in plants.Entities:
Mesh:
Year: 2009 PMID: 18939963 PMCID: PMC2667644 DOI: 10.1111/j.1365-313X.2008.03705.x
Source DB: PubMed Journal: Plant J ISSN: 0960-7412 Impact factor: 6.417
Figure 1Usual (a) and modified (b) procedures for non-targeted metabolic profiling analysis using LC-MS. The new and improved steps in this study are highlighted in gray.
Figure 2Screenshot of the MS2T viewer.
The spectrum image of MS/MS data (upper panel) and other text records (retention time, precursor ion m/z, etc., in the lower text box) of the queried MS2T accession (ATH02p01290) is displayed in the web-based tool. The MS2T viewer is available on our website (http://prime.psc.riken.jp/).
MS2T-based peak annotation results
| Peak no. | Retention time (Rt) (min) | Annotation | MS2T ΔRt < 0.15 min | Compound ΔRt <0.05 min | KNApSAcK Δ | MassBank Hit score >0.8 | Literature Hit score >0.8 | |
|---|---|---|---|---|---|---|---|---|
| 204 | 0.888 | 138 | Trigonelline | ATH02p00017,ATH02p00339 | Trigonelline hydrochloride_CAS:6138-41-6, CAS: 535-83-1:pyridine-2-aldoximemethochloride_CAS: 51-15-0 | Trigonelline | ||
| 3293 | 1.31 | 480 | 3-Methylsulfinyl- | ATH02p03162,ATH02p03388 | 3-(methylsulfinyl)propylglucosinolate_CAS: 554-88-1 | |||
| 3417 | 1.573 | 494 | 4-Methylsulfinyl- | ATH01p01271,ATH01p01502,ATH02p03393,ATH02p03604 | 4-(methylsulfinyl)butylglucosinolate_CAS: 21414-41-5 | |||
| 4484 | 1.818 | 613 | Glutathione (oxidized form) | ATH02p04203,ATH02p04412 | Glutathione (oxidized form)_CAS: 27025-41-8 | C28H37O15: durantoside III | ||
| 99 | 1.911 | 121 | [Tyramine-NH3]+ | ATH02p00031 | Tyramine | |||
| 205 | 1.919 | 138 | Tyramine | Tyramine_CAS: 51-67-2 | ||||
| 1350 | 1.928 | 268 | Adenosine | ATH01p05470,ATH01p05473,ATH01p05679,ATH02p01278,ATH02p01281,ATH02p01572 | Adenosine_CAS: 58-61-7 | C9H18N1O8: miserotoxin,C10H14N5O4: adenosine,C13H18N1O3S1: U68204 | Adenosine | |
| 825 | 2.638 | 220 | Pantothenate | ATH01p05252,ATH02p00999,ATH02p01290 | Sodium | Pantothenate | ||
| 3520 | 3.357 | 505 | Indol-3-ylmethylglucosinolate | ATH01p01520,ATH01p01756,ATH02p03409,ATH02p03412,ATH02p03624,ATH02p03626 | 4-methoxyindole-3-ylmethyl-glucosinolate_CAS: 4356-52-9 | Cocarboxylase | ||
| 6090 | 3.5 | 757 | Quercetin-3- | ATH01p03512,ATH02p05004 | Quercetin-3- | C33H41O20: luteolin 7-rutinoside-3′-glucoside | Herbacetin-7- | |
| 5879 | 3.686 | 741 | Kaempferol-3- | ATH01p03327,ATH02p05006,ATH02p05009 | Kaempferol-3- | C33H41O19: apigenin7-rutinoside-4′-glucoside | Cyanidin 3-(glucoside)rhamnoside | |
| 3780 | 3.873 | 535 | 4-Methoxyindol-3-ylmethylglucosinolate | ATH01p01762 | 4-methoxyindole-3-ylmethyl-glucosinolate_CAS: 83327-21-3 | |||
| 4455 | 3.923 | 611 | Quercetin-3- | ATH01p02728,ATH01p02938,ATH02p04216,ATH02p04219,ATH02p04429 | Quercetin-3- | C27H31O16: isoscutellarein7-allosyl-(1→2)-glucoside,luteol, C28H35O15: hesperidin,neohesperidin, C31H31O13: 4′- | Herbacetin-7- | |
| 4285 | 4.211 | 595 | Kaempferol-3- | ATH01p02244,ATH01p02732,ATH01p02735,ATH02p04021,ATH02p04024,ATH02p04220,ATH02p04223 | Kaempferol-3- | C30H27O13: apigenin 7-(6′’-E-caffeoylglucoside);7-[[6- | Cyanidin 3-glucoside,cyanidin 3-galactoside,cyanidin 3-(6′’-coumaroyl)glucoside | |
| 4115 | 4.557 | 579 | Kaempferol 3,7- | ATH01p02248,ATH01p02737,ATH01p02740,ATH02p03840,ATH02p04030 | Kaempferol 3,7- | C28H35O13: podorhizol β- | Cyanidin 3-(glucoside)rhamnoside | |
| 1649 | 1.446 | 308 | Glutathione (reduced form) | ATH01p05951,ATH01p06241,ATH02p01565,ATH02p01876 | C10H18N3O6S1: | Glutathione (reduced form) | ||
| 465 | 1.835 | 182 | Tyrosine | ATH01p04635,ATH01p04938 | Tyr | |||
| 350 | 2.486 | 166 | Phenylalanine | ATH01p03885,ATH01p04646,ATH02p00363,ATH02p00684,ATH02p00687 | C9H12N1O2: | Phe | ||
| 666 | 3.145 | 205 | Tryptophan | ATH01p04959,ATH01p05257,ATH02p01007 | C11H13N2O2: | Trp | ||
| 3000 | 4.245 | 449 | Quercetin-3,7- | ATH01p00839,ATH01p01074,ATH02p02980,ATH02p02983,ATH02p03204,ATH02p03207 | Luteolin-8-C-glucoside_CAS:28608-75-5 | C21H21O11: fisetin 8-C-glucosideC25H21O8: artonin P, C18H25O13:aralidioside | ||
| 2849 | 4.557 | 433 | Kaempferol 3,7- | ATH01p00842,ATH01p00845,ATH01p01079,ATH02p02985,ATH02p02988,ATH02p03209 | Apigenin 8-C-glucoside_CAS: 3681-93-4 | C25H21O7: calomelanol G; 3,4,7,8-tetrahydro-5-hydroxy-4-(4-hy,C24H33O5S1: ( | ||
| 516 | 3.137 | 188 | [Trp-NH3]+ | ATH01p04655,ATH01p04960,ATH02p00374,ATH02p00695 | C11H10N1O2: indole-3-acrylic acid | Trp | ||
| 3287 | 5.073 | 479 | Isorhamnetin-3- | Isorhamnetin-3- | ||||
| 5708 | 4.557 | 725 | Kaempferol-triRha | ATH02p05021 | ||||
| 4010 | 4.228 | 565 | Kaempferol(tetrahydroxy flavone)-Rha-pentoside | ATH01p02012,ATH02p03835 | Cyanidin 3-(glucoside)rhamnoside | |||
| 4284 | 3.83 | 595 | Kaempferol (tetrahydroxy flavone)-Hex-Rha | ATH01p02239,ATH01p02726,ATH01p02729,ATH02p04018 | C34H27O10: agathisflavonetetramethyl ether,cupressuflavone,C27H31O15:paniculatin, apigenin7-allosyl-(1→2)-glucoside | Cyanidin 3-glucoside,cyanidin 3-galactoside,kaempferol-7- | ||
| 5883 | 4.312 | 741 | Kaempferol (tetrahydroxy flavone)-Hex-diRha | ATH01p03336,ATH01p03339,ATH02p05017 | C44H37O11:guibourtinidol-(4α→ 2)-3,5,4′-trihydroxystilben | Cyanidin 3-(glucoside)rhamnoside, cyanidin3-(6′’-coumaroyl)glucoside | ||
| 6091 | 4.05 | 757 | Kaempferol (tetrahydroxy flavone)-diHex-Rha; quercetin-Hex-diRha | ATH01p03518,ATH02p05012 | C44H37O12: guibourtinidol-(4α→2)-3,5,3′,4′-tetrahydroxys, | Cyanidin 3-(glucoside)rhamnoside | ||
| 4456 | 4.312 | 611 | Kaempferol (tetrahydroxy flavone)-diHex | ATH01p02734,ATH01p02943,ATH02p04222,ATH02p04225,ATH02p04434,ATH02p04436 | C28H35O15: hesperidin, neohesperidin,4,2′,4′-trihydroxy-6′-m, C31H31O13:4′- | Cyanidin 3-glucoside, cyanidin3-galactoside, cyanidin3-sophoroside, cyanidin3-diglucoside, cyanidin3-laminaribiose | ||
| 3001 | 4.312 | 449 | Kaempferol (tetrahydroxy flavone)-diHex (fragment) | ATH01p00839,ATH01p01074,ATH02p02983,ATH02p03204,ATH02p03207 | C21H21O11: fisetin 8-C-glucosideC25H21O8: artonin P,C18H25O13: aralidioside | |||
| 2848 | 4.211 | 433 | Kaempferol (tetrahydroxy flavone)-3- | ATH01p00837,ATH01p01072,ATH02p02979,ATH02p02982,ATH02p03203,ATH02p03206 | C25H21O7: calomelanol G,C21H21O10: apigenin 7- | |||
| 4283 | 3.686 | 595 | Kaempferol (tetrahydroxy flavone)-3- | ATH01p02235,ATH01p02726,ATH02p04014,ATH02p04212 | C27H31O15(3): paniculatin, apigenin7-allosyl-(1→2)-glucoside,C34H27O10: agathisflavonetetramethyl ether, cupressuflavone, | Cyanidin 3-(glucoside)rhamnoside, cyanidin3-(6′’-coumaroyl)glucoside | ||
| 2847 | 3.686 | 433 | Kaempferol (tetrahydroxy flavone)-3- | ATH01p00829,ATH01p01063,ATH02p02971,ATH02p03196 | C21H21O10: apigenin 7- | |||
| 5200 | 4.27 | 681 | Kaempferl (tetrahydroxy flavone)-Hex-Rha-malonyl | ATH01p03162,ATH02p04625,ATH02p04818 | C34H33O15: okanin 4′-(2′’,4′’-diacetyl-6′’- | |||
| 4127 | 4.033 | 581 | Quercetin (pentahydroxy flavone)-Rha-pentoside | ATH01p02241,ATH01p02730,ATH02p04020,ATH02p04217 | C33H25O10: sciadopitysin, 7,7′’,4′’’-tri- | Herbacetin-7- | ||
| 4454 | 3.517 | 611 | Quercetin (pentahydroxy flavone)-Hex-Rha | ATH01p02723,ATH01p02932,ATH02p04210,ATH02p04420,ATH02p04423 | C31H31O13: 4′- | Delphinidin 3-(6′’-coumaroyl)glucoside,delphinidin 3-rutinoside,delphinidin 3-glucoside,rutin, delphinidin3-galactoside | ||
| 4661 | 4.042 | 627 | Quercetin (pentahydroxy flavone)-diHex | ATH01p02939,ATH02p04218,ATH02p04430 | C27H31O17: 6-hydroxyluteolin 7-sophoroside,6-hydroxyluteolin, C35H31O11: kuwanon L,C30H27O15: 6-hydroxykaempferol 7-(6′’-(E)-caffeylglucoside) | Delphinidin 3-glucoside,delphinidin 3-galactoside | ||
| 3155 | 4.042 | 465 | Quercetin (pentahydroxyflavone)-diHex (fragment) | ATH01p01069,ATH01p01301,ATH02p03202,ATH02p03419 | C21H21O12: gossypetin 8-rhamnoside,C18H25O12S1: paederosidic acid, | |||
| 2999 | 3.94 | 449 | Quercetin (pentahydroxy flavone)-3- | ATH01p00833,ATH01p01067,ATH02p02977,ATH02p03201 | C21H21O11: fisetin 8-C-glucoside;8-C-glucosylfisetin, isoorie,C25H21O8: 8,9-dihydro-6,11-dihydroxy-3,3-dimethyl- | |||
| 2998 | 3.517 | 449 | Quercetin (pentahydroxy flavone)-3- | ATH01p00826,ATH01p01060,ATH02p02969 | C21H21O11: fisetin 8-C-glucoside;8-C-glucosylfisetin, isoorie, | |||
| 4286 | 4.371 | 595 | Isorhamnetin (tetrahydroxymethoxyflavone)-Rha-pentoside | ATH01p02735,ATH02p04024,ATH02p04027,ATH02p04223 | C27H31O15: paniculatin,apigenin 7-allosyl-(1→2)-glucoside, C34H27O10:agathisflavone tetramethylether | |||
| 5545 | 4.625 | 711 | Isorhamnetin(tetrahydroxymethoxyflavone)-Hex-Rha-malonyl | ATH02p04819 | ||||
| 4635 | 3.915 | 625 | Isorhamnetin(tetrahydroxymethoxyflavone)-Hex-Rha | ATH02p04215,ATH02p04427 | C25H33N6O13: nikkomycin | Petunidin 3-glucoside,petunidin 3-galactoside | ||
| 4637 | 4.27 | 625 | Isorhamnetin(tetrahydroxymethoxyflavone)-Hex-Rha | ATH02p04221,ATH02p04224,ATH02p04435 | C27H29O17: luteolin 7-glucuronide-3′-glucoside | Petunidin 3-(6′’-coumaroyl)glucoside | ||
| 3139 | 4.261 | 463 | Isorhamnetin(tetrahydroxymethoxyflavone)-Hex-Rha (fragment) | ATH01p01305,ATH02p03205,ATH02p03423 | Brevifoliol | |||
| 4432 | 4.625 | 609 | Isorhamnetin(tetrahydroxymethoxyflavone)-diRha | ATH01p02738,ATH01p02947,ATH02p04029,ATH02p04032,ATH02p04228 | C28H33O15: physcion 8-gentiobioside,luteolin 3′-methyl ether, C35H29O10:olivieriflavone | |||
| 3140 | 4.625 | 463 | Isorhamnetin(tetrahydroxymethoxyflavone)-diRha (fragment) | ATH02p03210,ATH02p03428,ATH02p03431 | C25H19O9: sapurimycin | Brevifoliol | ||
| 691 | 4.845 | 207 | Sinapoymalate (fragment) | ATH01p04987,ATH01p05285,ATH02p00722,ATH02p01034,ATH02p01037 | C10H11N2O1S1: 3-indolylmethylthiohydroximate,C8H15O2S2: ( | |||
| 692 | 4.921 | 207 | Sinapoymalate (isomer, fragment) | ATH01p04991,ATH01p05285,ATH01p05288,ATH02p00727,ATH02p01034, ATH02p01037 | C10H11N2O1S1: 3-indolylmethylthiohydroximate,C11H11O4: lathodoratin, scoparone, C8H15O2S2:( | |||
| 5832 | 4.921 | 737 | Sinapoymalate (isomer, adduct) | ATH01p03345, ATH02p05025 | ||||
| 5831 | 4.837 | 737 | Sinapoymalate (adduct) | ATH01p03345, ATH02p05025 | ||||
| 2199 | 0.981 | 358 | 4-Methylsulfinyl- | ATH01p00006, ATH01p00268,ATH02p02175, ATH02p02178,ATH02p02438 | C20H12N3O4: BE 13793C | |||
| 602 | 0.981 | 196 | 4-Methylsulfinyl- | ATH01p04622, ATH02p00659,ATH02p00662, ATH02p00971,ATH02p00974 | ||||
| 2200 | 1.564 | 358 | 4-Methylsulfinyl- | ATH01p00011, ATH01p00278,ATH02p02185 | C20H12N3O4: BE 13793C | Tyrosine methyl ester,glucosaminate | ||
| 603 | 1.564 | 196 | 4-Methylsulfinyl- | ATH01p04630, ATH02p00668,ATH02p00980 | ||||
| 2310 | 1.962 | 372 | 5-Methylsulfinyl- | ATH01p00015 | 2α-Scetoxy-2′β-deacetylaustrospicatine | |||
| 727 | 1.962 | 210 | 5-Methylsulfinyl- | |||||
| 3541 | 1.962 | 508 | 5-Methylsulfinyl- | ATH01p01504, ATH01p01741,ATH01p01743, ATH02p03397,ATH02p03610 | C10H16N5O13P2S1:3′-phosphoadenosine5′-phosphosulfate | Loperamide,albendazole, | ||
| 3669 | 2.325 | 522 | 6-Methylsulfinyl- | ATH01p01508, ATH01p01746,ATH02p03614, ATH02p03812 | ||||
| 2572 | 2.799 | 400 | 7-Methylsulfinyl- | ATH01p00563, ATH01p00566,ATH01p00815, ATH02p02722,ATH02p02959 | C20H22N3O6: pelagiomicin A | Cloquintocet-mexyl,ketamine | ||
| 1102 | 2.799 | 238 | 7-Methylsulfinyl- | ATH02p01000, ATH02p01292 | ||||
| 3785 | 2.799 | 536 | 7-Methylsulfinyl- | ATH01p01747, ATH01p01991,ATH02p03619, ATH02p03621,ATH02p03816, ATH02p03819 | Simeconazole,triadimefon | |||
| 3275 | 3.044 | 478 | 4-Methylthio- | ATH01p01287, ATH01p01290,ATH01p01515, ATH02p03188,ATH02p03406 | ||||
| 2057 | 3.052 | 342 | 4-Methylthio- | ATH01p00029, ATH01p06265,ATH02p02207 | C17H16N3O5: pelagiomicin C | |||
| 3903 | 3.314 | 550 | 8-Methylsulfinyl- | ATH01p02001, ATH01p02230,ATH01p02233, ATH02p03821,ATH02p04007, ATH02p04010 | ||||
| 2690 | 3.323 | 414 | 8-Methylsulfinyl- | ATH01p00573, ATH01p00825,ATH02p02728, ATH02p02966 | C17H24N3O9: SB 219383,C22H24N1O7: α-narcotine,synerazol | |||
| 1230 | 3.323 | 252 | 8-Methylsulfinyl- | ATH01p05491, ATH01p05699,ATH02p01299, ATH02p01302,ATH02p01595 | C10H14N5O3: cordycepin,oxetanocin | |||
| 2284 | 3.348 | 369 | Indol-3-ylmethylglucosinolate (fragment) | ATH01p00036, ATH02p02211,ATH02p02472 | C20H17O7: averufin, velloquercetin,malaccol C16H21N2O6S1(1): 3-indolylmethyldesulfoglucosinolate | |||
| 685 | 3.348 | 207 | Indol-3-ylmethylglucosinolate (fragment) | ATH01p04963, ATH01p05260,ATH02p00699 | C11H11O4: lathodoratin, scoparone,C10H11N2O1S1: 3-indolylmethylthiohydroximate, C8H15O2S2: ( | |||
| 2557 | 3.873 | 399 | 4-Methoxyindol-3-ylmethylglucosinolate(fragment) | ATH01p00310, ATH01p00581 | ||||
| 1091 | 3.881 | 237 | 4-Methoxyindol-3-ylmethylglucosinolate(fragment) | ATH01p05268, ATH01p05499 | C14H9N2O2: 11-hydroxycanthin-6-one,C12H13O5: 5,6,7-trimethoxycoumarin,orthosporin, NSC 118343 | |||
| 2558 | 4.464 | 399 | 1-Methoxyindol-3-ylmethylglucosinolate(fragment) | ATH01p00320, ATH01p00590 | ||||
| 859 | 5.251 | 222 | 7-Methylthio- | ATH01p05291 | ||||
| 3649 | 5.251 | 520 | 7-Methylthio- | ATH01p01544, ATH01p01780 | ||||
| 1078 | 5.987 | 236 | 8-Methylthio- | ATH01p05300, ATH01p05525 | ||||
| 2549 | 5.987 | 398 | 8-Methylthio- | ATH01p00342 | ||||
| 3774 | 5.987 | 534 | 8-Methylthio- | ATH01p01786, ATH01p02036 | ||||
| 6168 | 5.877 | 764 | Spermidine-trisinapyl | ATH02p05211 | ||||
| 5681 | 5.53 | 722 | Spermidine-trihydroxyferuloyl | ATH01p03349, ATH02p04829,ATH02p05032 | ||||
| 3184 | 4.6 | 468 | Spermidine- | ATH01p01080, ATH01p01310,ATH02p03212, ATH02p03430 | C27H34N1O6: (+)-pyripyropene G | |||
| 3869 | 5.877 | 544 | Spermidine-hydroxyferuloyl-sinapyl | ATH01p02033, ATH02p03657,ATH02p03660, ATH02p03854,ATH02p03856 | ||||
| 6022 | 6.232 | 750 | Spermidine-hydroxyferuloyl-disinapyl | ATH01p03534, ATH02p05042 | ||||
| 3711 | 4.557 | 528 | Spermidine-feruloyl-sinapyl | ATH02p03642, ATH02p03842 | ||||
| 3589 | 4.388 | 514 | Spermidine-feruloyl-hydroxyferuloyl | ATH02p03425, ATH02p03636 | ||||
| 3956 | 4.676 | 558 | Spermidine-disinapyl | ATH01p02018, ATH02p03841 | ||||
| 4341 | 3.83 | 600 | Spermidine-di- | ATH02p04015, ATH02p04214 | β- | |||
| 2905 | 4.659 | 438 | Spermidine-di- | ATH01p00843, ATH01p00846,ATH01p01078, ATH01p01081,ATH02p02987, ATH02p02991,ATH02p03211, ATH02p03214 | C25H32N3O4: lunarine,C12H24N1O10S3: 4-methylsulfinylbutyl glucosinolate,C26H32N1O5: decaline | |||
| 5827 | 5.902 | 736 | Spermidine-dihydroxyferuloyl-sinapyl | ATH01p03353, ATH02p05036,ATH02p05038 | ||||
| 3733 | 5.53 | 530 | Spermidine-dihydroxyferuloyl | ATH02p03850 | ||||
| 5301 | 6.325 | 690 | Spermidine-diferuloyl-hydroxyferuloyl | ATH02p04640, ATH02p04838 | ||||
| 3454 | 4.87 | 498 | Spermidine-diferuloyl | ATH01p01312, ATH01p01539,ATH02p03432, ATH02p03644 | ||||
| 5493 | 5.911 | 706 | Spermidine-caffeoyl-hydroxyferuloyl-sinapyl | ATH01p03354, ATH02p04834,ATH02p05037 | ||||
| 7815 | 5.386 | 898 | Spermidine-caffeoyl-dihydroxyferuloyl-sinapyl | ATH02p05422 | ||||
Figure 3Metabolic profiles of four distinct Arabidopsis tissues.
The log2-transformed values are represented using a heat map. Hierarchical clustering of peaks was performed for the entire metabolic profile dataset (32 columns × 1233 rows).
Figure 4MS/MS spectra of the MS2Ts tagged to (a) the 5879th peak (ATH01p03327, kaempferol-3-O-rhamnosyl(1,2)-glucoside-7-O-rhamnoside), (b) the 4115th peak (ATH01p02248, kaempferol-3,7-O-dirhamnoside), and (c) the 4465th peak (ATH02p0422, kaemferol dihexoside). The deduced neutral losses of hexose (Δ162.0528 Da) and rhamnose (Δ146.0579 Da) are indicated in the spectra.
Figure 5Inter-tissue comparison of the levels of 44 identified metabolites. The log2-transformed intensity values are represented using a heat map.
Deduced annotation, MS2T data and relative peak intensity of the inflorescence tissue-specific metabolites
| Relative intensity (internal standard = 1.0) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Peak no. | Retention time (min) | Mass ( | Tentative annotation | MS2T code (representative) | MS2T data | Inflorescence | Cauline leaf | Rosette leaf | Stem |
| 1408 | 3.23 | 277 | ATH01p05697 | 91.0494 (37), 114.1023 (14),119.0486 (48), 147.0452 (100),218.1225 (6), 260.1430 (8) | 0.004 ± 0.002 | 0.003 ± 0.001 | 0.065 ± 0.037 | 0.003 ± 0.001 | |
| 2156 | 3.957 | 344 | Sinapoylglutamate, putative | ATH01p00314 | 91.0492 (13), 119.0483 (13),147.0459 (14), 175.0428 (30),207.0664 (100) | 0.045 ± 0.008 | 0.010 ± 0.005 | 0.004 ± 0.001 | 0.006 ± 0.003 |
| 2905 | 4.66 | 438 | Di- | ATH02p02987 | 91.0556 (18), 119.0524 (41),147.0492(100), 204.1110 (19),292.2118 (8), 438.2540 (20) | 0.880 ± 0.292 | 0.003 ± 0.001 | 0.003 ± 0.000 | 0.003 ± 0.001 |
| 3453 | 4.69 | 498 | Di-feruloylspermidine, putative | ATH02p03429 | 72.0766 (5), 117.0284 (5),145.0239 (17), 177.0498 (45),234.1055 (24), 305.1812 (8),322.2060 (29), 498.2472 (100) | 0.669 ± 0.320 | 0.003 ± 0.001 | 0.003 ± 0.000 | 0.003 ± 0.001 |
| 5681 | 5.53 | 722 | Tri-hydroxyferuroylspermidine,putative | ATH02p04827 | 193.0454 (46), 250.0949 (50),530.2488 (100), 722.2715 (65) | 0.877 ± 0.593 | 0.014 ± 0.012 | 0.003 ± 0.000 | 2.974 ± 0.623 |
| 5827 | 5.90 | 736 | Di-hydroxyferuroyl-sinapoylspermidine, putative | ATH02p05036 | 161.0204 (6), 175.0361 (8),193.0451 (15), 207.0619 (14),250.1024 (23), 321.1768 (7),338.2016 (9), 352.2197 (9),526.2460 (18), 544.2592 (76),736.2964 (100) | 3.695 ± 0.045 | 0.003 ± 0.001 | 0.003 ± 0.000 | 0.003 ± 0.001 |
| 6022 | 6.23 | 750 | Hydroxyferuroyl-di-sinapoylspermidine,putative | ATH02p05039 | 147.0427 (7), 175.0362 (18),193.0451 (24), 207.0594 (65),250.0997 (34), 264.1103 (11),321.1663 (12), 338.1973 (8),352.2212 (17), 526.2408 (33),544.2575 (91), 545.2682 (9),558.2371 (13), 750.3192 (100) | 0.393 ± 0.208 | 0.003 ± 0.001 | 0.003 ± 0.000 | 0.003 ± 0.001 |
Figure 6MS/MS spectra of (a) the 1408th peak (ATH01p05697, p-coumaroylagmatine, putative), (b) the 2905th peak (ATH02p02987, di-p-coumaroylspermidine, putative) and (c) the 2156th peak (ATH01p00314, sinapoylglutamate, putative). Tentatively deduced structures are also shown.
Figure 7Metabolic profiles of Arabidopsis mutant lines with disruption in putative UDP-dependent glycosyltransferase (UGT) or methyltransferase family genes by insertion of the Ds transposon. Two-week-old seedlings of 60 mutant lines and 13 wild-type (F-Nossen) parent lines were analyzed (219 samples in total, n =3), and the metabolic profile data were processed to obtain a matrix containing 1808 rows. The log2-transformed intensity data are normalized and hierarchically clustered using average linkage methods with the Euclidean distance function. The intensities of 59 peaks in the matrix are represented using a heat map.